Atopic Dermatitis study: VC005 group
Official title A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov ID: NCT07598383
What this study is testing
What is VC005?
VC005 is an investigational topical gel being studied as a potential treatment for atopic dermatitis.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether VC005 gel (a skin gel) works and is safe for adults with mild to moderate atopic dermatitis.
- Who it's for
- You may be able to join if you are an adult with mild to moderate atopic dermatitis.
- What's involved
- You will apply the gel to your skin for a set time. Neither you nor the doctors will know if you get the real gel or a pretend gel.
- Time commitment
- The study lasts several weeks with regular clinic visits.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- people fully understand this study, are able to follow the relevant procedures of the trial, voluntarily participate in the clinical trial, and sign...
- The age requirement for signing the ICF is 18 years old or above, with no gender restrictions;
- During screening, the diagnosis of atopic dermatitis should be met according to the Hanifin-Rajka criteria.
You likely can't join if
- Patients judged by the investigator to have an unstable course of Atopic Dermatitis (AD) (spontaneous improvement or rapid deterioration) within 2...
- Patients with skin lesions limited to the hands or feet at screening and baseline, with no prior history of involvement in other typical areas (such...
- Skin damage or abnormalities that may affect the evaluation of the investigational drug administration site (e.g., hyperpigmentation, large-area...
- Presence of skin diseases at screening and baseline that may affect the evaluation of the administration site, including but not limited to...
- Patients with a history of malignant tumors, with the exception of: cervical carcinoma in situ, non-metastatic cutaneous squamous cell carcinoma or...
The study team makes the final eligibility decision.
Where it is enrolling
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hangzhou, Zhejiang, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.